Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Татьяна Федоровна Корява, Василий Васильевич СимрокfiledCriticalТатьяна Федоровна Корява
Priority to UAU201215022UpriorityCriticalpatent/UA80461U/en
Publication of UA80461UpublicationCriticalpatent/UA80461U/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
A method for treating the placental dysfunction with circulatory disorders in the uterine, umbilical and middle cerebral arteries in the pregnant patients with pre-eclampsia with concomitant hepatobiliary pathology comprises sedative, hypotensive, magnesium and infusion therapy. In addition, Tivortin is administered, first intravenously dropwise as 4.2 % solution in a volume of 100 mL once a day for 5 consecutive days and then orally, one tablespoon thrice a day for 8-10 days. Curantyl is used thrice a day at a dose of 25 mg for 10-15 days depending on the attained effect.
UAU201215022U2012-12-272012-12-27Method for treating placental dysfunction in pregnant patients with pre-eclampsia with concomitant hepatobiliary pathology
UA80461U
(en)